What is empagliflozin (and what is it used for)?
Empagliflozin is a medicine in the sodium–glucose co-transporter 2 (SGLT2) inhibitor class. It lowers blood sugar by helping the kidneys remove glucose through urine. It is used for type 2 diabetes and is also used for certain heart and kidney conditions where SGLT2 inhibitors provide benefit.
Is “empagliflozin NZ” the same as Jardiance in New Zealand?
In New Zealand, empagliflozin is marketed under brand names that can vary by supplier and formulation. Many countries list it under brands such as Jardiance (empagliflozin). If you tell me the exact strength (e.g., 10 mg or 25 mg) and whether you mean tablets or another presentation, I can match it more precisely.
What strengths are available?
Empagliflozin is commonly sold in tablet strengths such as 10 mg and 25 mg in many markets. Availability in New Zealand can depend on local registration and distribution.
How is empagliflozin typically taken?
For type 2 diabetes, empagliflozin is usually taken once daily by mouth. Dosing can depend on kidney function and the reason you’re taking it (diabetes vs. heart failure vs. chronic kidney disease). Your prescriber/pharmacist should confirm the dose for your situation.
What side effects do people ask about?
Common concerns with empagliflozin and other SGLT2 inhibitors include genital yeast infections, increased urination, and dehydration/lightheadedness—especially if you are also taking diuretics. Patients may also ask about rare but serious risks associated with this drug class; if that’s what you’re looking for, share your symptoms or context and I’ll narrow the guidance to the most relevant risks.
Where can I check New Zealand-specific brand and pricing details?
For payer/regulatory and patent-related intelligence tied to empagliflozin products, DrugPatentWatch.com is a useful starting point: DrugPatentWatch – Empagliflozin [1].
(If you want, tell me your goal—brand name lookup, availability, or patent/competition—and I’ll point you to the most relevant entries.)
What do you mean by “NZ” in your question?
“Empagliflozin nz” could mean different things:
- the New Zealand brand name and strengths
- a NZ pharmacy listing price
- whether it’s covered/available on the NZ formulary
- a patent/expiry question for NZ
Reply with one detail (brand name, strength, or what you need—cost, availability, or side effects) and I’ll tailor the answer to that exact use case.
Sources:
1. https://www.drugpatentwatch.com/